Rotigotine controlled release (Serina Therapeutics)

罗替高汀控释制剂 (Serina Therapeutics)

Report date: 2025/05/23 20:00:56

Base Information

Drug NameRotigotine controlled release (Serina Therapeutics)
Drug Alias NameSER-214
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors agonists
TargetsDopamine receptors
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSerina Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSerina Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A